Micardis Tablets — Class II drug recall D-0600-2021
Terminated recall by Boehringer Ingelheim Pharmaceuticals, Inc., reported 2021-06-09, distributed in AR, CO, CT, LA, NC, ND, NH, NJ…. Subpotent Drug
| Recall number | D-0600-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, United States |
| Recall initiated | 2021-05-04 |
| Classified | 2021-05-28 |
| Reported by FDA | 2021-06-09 |
| Terminated | 2021-10-14 |
| Distributed | AR, CO, CT, LA, NC, ND, NH, NJ, OH, PA, PR |
| Reason classes | potency |
| NDC | 00597-0041-37 |
| Lot numbers | 860412 |
Product
Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37), Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877
Reason for recall
Subpotent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0600-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.